Jorgen Persson

home

authors

jorgen-persson

Click             here for Audio/Video Version

          "Good morning, it's July 3, 2001 and we're at ESHRE in Lausanne.   Next to me is Jorgen Persson who is the Product Manager of Ferring.   Good morning, Jorgen."
       
       

  "I  want to talk with you about ESHRE as it is now and especially about the  symposium that Ferring had.  Can you tell us what the headlines of this  symposium were?"
       
       

  "Yes, the  headlines from the symposium were that we wanted to show the role of LH  and the importance to include LH into treatment of       any ovulation induction, IVF, and ART.  We had some new data  coming up from a recent largest study comparing highly purified HMG  Menopur® and Gonal-F®."
       
       

  "Is this the German study?"
       
       

  "This is a  multinational study so there was some sent to us from Germany as well  the Netherlands, the UK, Israel, and some other markets as well."
       
       

  "How many cycles were there?"
       
       

  "There were 727 cycles so it's the largest study so far."
       
       

  "What are the results of this study?"
       
       

  "The results showed that Menopur® is at least as effective as Gonal-F® in the treatment of IVF and ICSI patients."
       
       

  "What about side effects?"
       
       

  "The side  effects are comparable so you get the same treatment, and you could see a  trend in the study but this should be published further on in  journals."
       
       

  "We  can refer to the interview that we also have with the presenter of this  study.  Were there other papers that you presented in your symposium?"
       
       

  "Yes, we had a  very nice presentation from Dr. Lucas Klentzeris from the UK.  He  showed his results with Doppler examination of the women in the  development of their oocytes or follicles, I should say, and that was  interesting results."
       
       

  "This was the Doppler flow.  Why did you put this in your Ferring symposium?"
       
       

  "I think it  is innovation; it's a new technology that we started to use.  Lots of  physicians were very interested to see the results and the experience       he has  from this kind of examination.  He also showed very nice  data of the difference in patients in the blood flow in the ovarium if  they were treated with either highly purified HMG or if they were  treated with recombinant FSH."
       
       

  "Indeed, he had beautiful pictures and slides with nice colors.  Were there any others special topics within your symposium?"
       
       

  "Then we  introduced at the symposium a nice presentation from Zeleznik where he  showed us the two-cell theory and the importance of LH in the  treatment."
       
       

  "I  think this was a very interesting paper as well.  So indeed, this was a  very interesting symposium you presented.  Thank you very much, and I  must congratulate you on your symposium."
       
       

Articles

OBGYN.net Conference CoverageFrom the ESHRE 2001 Conference - Lausanne, Switzerland

Author | Jorgen Persson

Articles

Ferring Symposium